Literature DB >> 17198919

Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia.

Ronald G García1, Johanna Celedón, Jesús Sierra-Laguado, Miguel A Alarcón, Carlos Luengas, Federico Silva, Mario Arenas-Mantilla, Patricio López-Jaramillo.   

Abstract

BACKGROUND: The aim of this study was to investigate whether impaired flow mediated vasodilation precedes the clinical manifestations of preeclampsia and whether is associated with inflammation.
METHODS: We conducted a nested case-control study in a prospective cohort of 506 normotensive women recruited before the 30th week of gestation (mean gestational age of 21.8 weeks). At enrollment, flow-mediated dilation was measured in the brachial artery using a 7.5-MHz transducer. C-reactive protein plasma concentrations and leukocyte count were also determined at study entry. Patients were followed until delivery, and medical records were reviewed for each patient to confirm the presence or absence of preeclampsia or gestational hypertension.
RESULTS: Of the women studied, 14 developed preeclampsia, 18 developed gestational hypertension, and 474 remained normotensive. Two normotensive pregnant control subjects were randomly selected for each case, matched by maternal age, gestational age, and body mass index at enrollment. Women who subsequently developed preeclampsia had lower flow-mediated dilation (13.4% +/- 4.3% v 18.2% +/- 7.2, P = .026), higher C-reactive protein plasma concentrations (8.7 +/- 5.5 mg/dL v 5.3 +/- 4.3 mg/dL, P = .022) and leukocyte count (10.3 +/- 2.0 x 10(9)/L v 9.1 +/- 2.0 x 10(9)/L, P = .036) at study entry.
CONCLUSIONS: Decreased flow-mediated vasodilation and higher levels of CRP are present in early stages of gestation in women who subsequently develop preeclampsia. These alterations occur before the onset of clinical symptoms of PE. Further studies are needed to confirm that flow-mediated dilation and C-reactive protein could be useful methods to screen women at risk of developing preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17198919     DOI: 10.1016/j.amjhyper.2006.06.001

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  19 in total

Review 1.  Residual vascular dysfunction in women with a history of preeclampsia.

Authors:  Anna E Stanhewicz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-08-22       Impact factor: 3.619

Review 2.  Flow-mediated dilation: can new approaches provide greater mechanistic insight into vascular dysfunction in preeclampsia and other diseases?

Authors:  Tracey L Weissgerber
Journal:  Curr Hypertens Rep       Date:  2014-11       Impact factor: 5.369

Review 3.  Impaired Flow-Mediated Dilation Before, During, and After Preeclampsia: A Systematic Review and Meta-Analysis.

Authors:  Tracey L Weissgerber; Natasa M Milic; Jelena S Milin-Lazovic; Vesna D Garovic
Journal:  Hypertension       Date:  2015-12-28       Impact factor: 10.190

4.  Biological Consequences of Disturbed Sleep: Important Mediators of Health?

Authors:  Michele L Okun
Journal:  Jpn Psychol Res       Date:  2011-05-01

5.  Does C-reactive protein predict recurrent preeclampsia?

Authors:  Hilary S Gammill; Robert W Powers; Rebecca G Clifton; J Peter Van Dorsten; Mark A Klebanoff; Marshall D Lindheimer; Baha Sibai; Mark B Landon; Menachem Miodovnik; Mitchell Dombrowski
Journal:  Hypertens Pregnancy       Date:  2010       Impact factor: 2.108

6.  Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia.

Authors:  Frauke M von Versen-Hoeynck; Carl A Hubel; Marcia J Gallaher; Hilary S Gammill; Robert W Powers
Journal:  Am J Hypertens       Date:  2009-03-12       Impact factor: 2.689

7.  Maternal plasma soluble TRAIL is decreased in preeclampsia.

Authors:  Piya Chaemsaithong; Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Tamara Stampalija; Nandor Gabor Than; Zhong Dong; Jezid Miranda; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-13

Review 8.  Autonomic circulatory control during pregnancy in humans.

Authors:  Qi Fu; Benjamin D Levine
Journal:  Semin Reprod Med       Date:  2009-06-15       Impact factor: 1.303

9.  C-reactive protein is elevated 30 years after eclamptic pregnancy.

Authors:  Carl A Hubel; Robert W Powers; Sunna Snaedal; Hilary S Gammill; Roberta B Ness; James M Roberts; Reynir Arngrímsson
Journal:  Hypertension       Date:  2008-04-14       Impact factor: 10.190

10.  Inflammation and hypertension: are there regional differences?

Authors:  Patricio López-Jaramillo; Carlos Velandia-Carrillo; Julie Alvarez-Camacho; Daniel Dylan Cohen; Tatiana Sánchez-Solano; Gabriela Castillo-López
Journal:  Int J Hypertens       Date:  2013-03-21       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.